“高中签率”新股,来了!
中国基金报·2025-10-12 05:02

Group 1: New IPOs and Subscription Information - Five new stocks are available for subscription next week, with one stock available for each trading day [2] - Marco Polo's subscription code is 001386, with an issue price of 13.75 yuan per share and an issuance PE ratio of 14.27 times [4] - He Yuan Bio's subscription code is 787765, with a total issuance of 89.45 million shares [8] - Chao Ying Electronics' subscription code is 732175, with a total issuance of 52.5 million shares [12][13] - Xi'an Yicai's subscription code is 787783, with a total issuance of 538 million shares [18] - Biobetter's subscription code is 787759, with a total issuance of 90 million shares [24] Group 2: Company Performance and Financials - Marco Polo is the leading company in China's architectural ceramics industry, with projected revenues of 86.61 billion yuan in 2022, 89.25 billion yuan in 2023, and 73.24 billion yuan in 2024 [4] - He Yuan Bio's revenue for 2022 to 2024 is projected to be 13.39 million yuan, 24.26 million yuan, and 25.22 million yuan respectively, with net losses of 144 million yuan, 187 million yuan, and 151 million yuan [8][10] - Chao Ying Electronics' revenue for 2022 to 2024 is projected to be 3.514 billion yuan, 3.656 billion yuan, and 4.124 billion yuan, with net profits of 141 million yuan, 266 million yuan, and 276 million yuan [13] - Xi'an Yicai's revenue for 2022 to 2024 is projected to be 1.055 billion yuan, 1.474 billion yuan, and 2.121 billion yuan, with net losses of 412 million yuan, 578 million yuan, and 738 million yuan [18] - Biobetter's projected net losses for 2022 to 2024 are 188 million yuan, 173 million yuan, and 56 million yuan [24] Group 3: Market Position and Competitive Landscape - Marco Polo is positioned in the first tier of the architectural ceramics industry, competing with companies like Dongpeng Holdings and Mona Lisa [4] - He Yuan Bio focuses on innovative biopharmaceuticals, with its core product HY1001 being the first recombinant human albumin drug approved in China [8] - Chao Ying Electronics is among the top ten global automotive electronic PCB suppliers and one of the top five in China [13] - Xi'an Yicai is ranked as the number one manufacturer of 12-inch silicon wafers in mainland China and sixth globally [18] - Biobetter is focused on developing first-in-class drugs for major diseases, with significant ongoing R&D investments [24][27]